Jenö Szilbereky

Title: Jenő Szilbereky: Innovator in Pharmaceutical Research

Introduction

Jenő Szilbereky is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals with his research and inventions, holding a total of two patents. His work primarily focuses on treatments related to insulin resistance and vascular diseases.

Latest Patents

Jenő Szilbereky’s latest patents include N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance. This patent encompasses various methods for treating pathological insulin resistance, alongside complications associated with diabetes such as retinopathy, neuropathy, and nephropathy. Another significant patent of his is related to an optically active pyridyl-4H-1,2,4-oxadiazine derivative, specifically (−)-5,6-dihydro-5-(1-piperidinyl)-methyl-3-(3-pyridyl)-4H-1,2,4-oxadiazine, which highlights its therapeutic potential in treating vascular diseases.

Career Highlights

Throughout his career, Szilbereky has worked with several organizations, including Biorex Kutató és Fejlesztő Rt. His work at this institution has contributed to his recognition as an innovative thinker in the pharmaceutical industry.

Collaborations

Jenő Szilbereky has collaborated with several talented individuals, including Zita Csákai and Magdolna Török. These partnerships have enabled him to advance his research and bring forth groundbreaking innovations in the pharmaceutical field.

Conclusion

In summary, Jenő Szilbereky stands out as an influential inventor whose patents focus on critical health issues related to insulin resistance and vascular diseases. His career is marked by significant collaborations and contributions that continue to impact the pharmaceutical industry.